Ascendis Pharma A (ASND) Research & Development: 2014-2025
Historic Research & Development for Ascendis Pharma A (ASND) over the last 12 years, with Sep 2025 value amounting to -$78.2 million.
- Ascendis Pharma A's Research & Development rose 3.20% to -$78.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was $179.1 million, marking a year-over-year decrease of 2.49%. This contributed to the annual value of $332.3 million for FY2024, which is 25.30% down from last year.
- Per Ascendis Pharma A's latest filing, its Research & Development stood at -$78.2 million for Q3 2025, which was down 195.95% from $81.5 million recorded in Q2 2025.
- Ascendis Pharma A's 5-year Research & Development high stood at $121.3 million for Q3 2023, and its period low was -$80.8 million during Q3 2024.
- Over the past 3 years, Ascendis Pharma A's median Research & Development value was $89.9 million (recorded in 2024), while the average stood at $64.8 million.
- Its Research & Development has fluctuated over the past 5 years, first soared by 267.46% in 2021, then plummeted by 166.58% in 2024.
- Quarterly analysis of 5 years shows Ascendis Pharma A's Research & Development stood at $75.1 million in 2021, then surged by 47.55% to $110.8 million in 2022, then decreased by 11.76% to $97.8 million in 2023, then decreased by 13.35% to $84.7 million in 2024, then climbed by 3.20% to -$78.2 million in 2025.
- Its Research & Development stands at -$78.2 million for Q3 2025, versus $81.5 million for Q2 2025 and $91.1 million for Q1 2025.